Palla Pharma Ltd.
Palla Pharma Ltd. (ASX:PAL) (OTC:TPPIF), formerly TPI Enterprises Ltd. (ASX:TPE), is one of three licensed poppy processors in Australia, and the only Australian-owned company. As one of eight processors worldwide producing Narcotic Raw Material for the international pharmaceutical industry, The company’s expansion within Australia and Europe includes the introduction of new growing areas to ensure long term sustainability for the supply of raw materials. On September 29th, 2017 TPI Enterprises Ltd. announced that the Office of Drug Control granted the company a medicinal cannabis license and a cannabis research license. The cannabis research licence authorizes TPE to research the cultivation of cannabis plants and produce cannabis or cannabis resin for research relating to medicinal cannabis. The medicinal cannabis licence authorises TPE to cultivate cannabis plants and produce cannabis or cannabis resin for medicinal purposes.